|
|
|
Insider
Information: |
Arbuckle Stuart A |
Relationship: |
Director |
City: |
Cambridge, |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
62,795 |
|
Indirect Shares
|
140 |
|
|
Direct
Value |
$23,225,245 |
|
|
Indirect Value
|
$65,419 |
|
|
Total
Shares |
62,935 |
|
|
Total
Value |
$23,290,664 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-05-15 |
49,691 |
2024-05-15 |
140 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
192 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Comm & Ops Officer |
|
2021-05-17 |
4 |
AS |
$215.33 |
$23,589 |
D/D |
(109) |
41,103 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2021-11-15 |
4 |
AS |
$186.99 |
$562 |
D/D |
(3) |
41,103 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2022-05-02 |
4 |
AS |
$263.98 |
$80,778 |
D/D |
(306) |
64,760 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2022-05-16 |
4 |
AS |
$246.21 |
$33,408 |
D/D |
(133) |
64,760 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2022-08-09 |
4 |
AS |
$300.53 |
$1,710,817 |
D/D |
(5,690) |
60,996 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2022-08-10 |
4 |
AS |
$300.32 |
$54,073 |
D/D |
(180) |
60,880 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2022-08-15 |
4 |
AS |
$300.30 |
$6,738,991 |
D/D |
(22,173) |
45,278 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-13 |
4 |
AS |
$296.44 |
$1,460,816 |
D/D |
(4,887) |
82,003 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-14 |
4 |
AS |
$295.84 |
$1,910,962 |
D/D |
(6,398) |
75,605 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-21 |
4 |
AS |
$291.01 |
$705,596 |
D/D |
(2,402) |
68,705 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-22 |
4 |
AS |
$291.84 |
$706,679 |
D/D |
(2,401) |
66,304 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-27 |
4 |
AS |
$287.16 |
$1,447,143 |
D/D |
(5,034) |
56,556 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-05-30 |
4 |
AS |
$329.82 |
$27,045 |
D/D |
(82) |
56,556 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-12-13 |
4 |
AS |
$399.00 |
$3,432,597 |
D/D |
(8,603) |
56,556 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-12 |
4 |
AS |
$420.24 |
$1,804,931 |
D/D |
(4,295) |
75,718 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-20 |
4 |
AS |
$420.79 |
$2,021,475 |
D/D |
(4,804) |
63,042 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-21 |
4 |
AS |
$421.77 |
$1,519,637 |
D/D |
(3,603) |
59,439 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-26 |
4 |
AS |
$425.70 |
$2,142,974 |
D/D |
(5,034) |
49,691 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-05-15 |
4 |
AS |
$430.93 |
$29,734 |
D/D |
(69) |
49,691 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-10 |
4 |
D |
$240.95 |
$2,154,575 |
D/D |
(8,942) |
58,621 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-17 |
4 |
D |
$241.50 |
$602,784 |
D/D |
(2,496) |
44,839 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-24 |
4 |
D |
$239.23 |
$693,289 |
D/D |
(2,898) |
38,813 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-10 |
4 |
D |
$214.16 |
$664,110 |
D/D |
(3,101) |
66,856 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-17 |
4 |
D |
$211.75 |
$1,321,320 |
D/D |
(6,240) |
55,460 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-24 |
4 |
D |
$217.57 |
$630,518 |
D/D |
(2,898) |
44,737 |
0 |
- |
|
192 Records found
|
|
Page 5 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|